Suggestions
Gabriel Lopez
Founder and CEO at Synvivia
Gabriel Lopez is the CEO and founder of Synvivia, a synthetic biology company based in Berkeley, California.2 He co-invented the company's foundational technology while pursuing his Ph.D. in Bioengineering and Biomedical Engineering at UC Berkeley.1
Career and Education
Gabriel Lopez founded Synvivia in 2015.14 The company was part of the Y Combinator cohort in 2016.1 Prior to founding Synvivia, Lopez worked at UC Berkeley from 2008 to 2010.5
After completing his Ph.D., Lopez expanded on his doctoral work as a postdoc in the lab of UC Berkeley Professor of Entomology John Anderson, where he developed new protein engineering architectures and workflows.1
Synvivia
Synvivia is a biotechnology company that focuses on:
- Optimizing cell behavior for gene therapy manufacturing1
- Developing genetically encoded biocontainment technologies1
- Applying chemical control over cell behavior to improve biomanufacturing of high-value biopharmaceutical products2
The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. Synvivia's work has been published in ACS Synthetic Biology and featured as an Editor's Choice in Science Magazine.1
Recognition and Funding
Synvivia has received backing from:
- Y Combinator
- National Institutes of Health
- Industrial partnerships1
The company is also part of the California Innovation Fund's portfolio.4
Gabriel Lopez's LinkedIn profile indicates that he has over 500 connections and is based in Berkeley, California.3
Highlights
![High school football roundup: Deer Valley stuns Freedom, snaps 16-game losing streak - The Mercury N](https://www.mercurynews.com/wp-content/uploads/2021/04/BNG-L-DEANZA-0416-8.jpg?w=1024&h=683)